ESG-labeled funds increased exposure to nuclear weapons manufacturers by 95% between 2024 and 2025, according to Bloomberg. Of 1,200 ESG funds analyzed — totaling $4.2 trillion in assets — 37% held at least one ICAN-identified nuclear weapons company, up from 19% the prior year. Methodological gaps among ESG rating agencies enabled inclusion of firms like Lockheed Martin and Raytheon Technologies in 214 ESG-branded funds. Regulatory pressure intensified after ESMA’s March 2025 guidance and the $1.1 trillion Investor Initiative on Nuclear Weapons launched in Q2 2025.
According to www.bloomberg.com, exposure to nuclear weapons manufacturers within exchange-traded funds (ETFs) and mutual funds marketed as environmentally, socially, and governance (ESG)-aligned rose by 95% between 2024 and 2025.
Sharp Increase in Controversial Holdings
The surge reflects a measurable expansion in fund holdings of companies involved in the design, production, or maintenance of nuclear arms systems — including firms supplying components to national defense contractors. Bloomberg’s analysis covered over 1,200 ESG-labeled funds domiciled primarily in the EU and US, with combined assets under management exceeding $4.2 trillion. Of those, 37% held at least one company identified by the International Campaign to Abolish Nuclear Weapons (ICAN) as contributing to nuclear weapons programs — up from 19% in the prior year.
Methodology Gaps and Rating Discrepancies
The rise stems largely from inconsistencies in ESG rating methodologies across major providers. Funds rated highly by MSCI and Sustainalytics often excluded nuclear weapons involvement from their ‘controversial weapons’ screens, focusing instead on cluster munitions, landmines, or chemical weapons. As a result, firms like Lockheed Martin, Northrop Grumman, and Raytheon Technologies — all listed in ICAN’s 2025 Nuclear Weapons Company Index — appeared in 214 ESG-branded funds as of June 2025. One top-tier European ESG ETF increased its allocation to nuclear-capable defense contractors by 140% year-on-year, adding positions worth €87 million.
Regulatory and Investor Response
European regulators have escalated scrutiny following the publication of the Corporate Sustainability Due Diligence Directive (CSDDD), which explicitly requires asset managers to assess adverse human rights and environmental impacts across value chains — including military supply chains. The European Securities and Markets Authority (ESMA) issued guidance in March 2025 urging fund managers to disclose weapons-related exposures in pre-contractual documentation. Meanwhile, institutional investors representing over $1.1 trillion in assets signed the Investor Initiative on Nuclear Weapons in Q2 2025, demanding standardized exclusion criteria and third-party verification.
Practical Implications for Portfolio Oversight
For compliance officers and ESG integration teams, the data signals a critical gap between marketing claims and underlying portfolio composition. Supply chain professionals managing investment-grade ESG mandates must now verify not only direct supplier policies but also tier-two and tier-three subcontractors embedded in defense industrial networks — particularly where dual-use technologies (e.g., advanced semiconductors, high-performance computing hardware) intersect with weapons systems. According to the report, 68% of nuclear-linked holdings occurred via indirect exposure through diversified aerospace and defense conglomerates rather than direct weapons producers.
Source: Bloomberg
Compiled from international media by the SCI.AI editorial team.
